weight loss glp-1 agonists - What is it? GLP-1 and health: Beyond weight
Description
Zhang et al., 2024
Griffith D
3.3.4 Publication Bias Eggers tests were conducted to detect publication bias
Abstract Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrome, increases worldwide representing now the prevalent liver disease in western countries
Diabetes Obes Metab 2013;15:770-3.ArticlePubMed 113
What diseases are treated using receptor agonists
